Mizuho Reiterates Outperform Rating on Emerson (EMR), 'Top Pick heading into '26'

November 21, 2025 6:36 AM EST Send to a Friend
Mizuho analyst Brett Linzey reiterated an Outperform rating and $155.00 price target on Emerson (NYSE: EMR).The analyst commented: "EMR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login